AIVIS Presents Breast Cancer Biomarker Ki-67 Digital Pathology AI Validation Study at ESMO Breast Cancer 2026
Editor2026-06-02T15:11:15+00:00AIVIS (CEO Daehong Lee), a company specializing in artificial intelligence (AI)-powered pathology image analysis solutions, announced today that it presented its research findings on the performance validation of its breast cancer Ki-67 Digital Image Analysis (DIA) at ESMO Breast Cancer 2026, held in Berlin, Germany, from May 6 to 8. ESMO Breast Cancer 2026 is a [...]










